Usage of Orange Peel Extract in Management of Epistaxis

Launched by MINIA UNIVERSITY · Feb 15, 2025

Keywords

ClinConnect Summary

This clinical trial is exploring the use of orange peel extract as a treatment for epistaxis, which is the medical term for nosebleeds, specifically in children. The researchers want to see if the natural extract from orange peels can help stop nosebleeds that occur in a specific area inside the nose called Little’s area. The trial is not currently recruiting participants, but once it starts, children aged 2 to 18 who experience anterior nosebleeds will be eligible to participate.

To be included in the study, children must have nosebleeds from the front part of the nose and should not have any issues like nasal polyps (growths in the nose), blood disorders, or other health conditions that affect how their blood clots. If a child participates, they can expect to receive the orange peel extract and be monitored to see how well it works in managing their nosebleeds. This trial is significant because it could offer a new, natural option for treating a common problem in children.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • children with anterior epistaxis from little's area
• Exclusion Criteria:
• • patient with nasal polyp.
• • patients with hematological abnormalities.
• • patients with general diseases affecting coagulation system.